The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMAG Pharmaceuticals, Inc. | COM | 00163U106 | 42,765 | 1,761,332 | SH | SOLE | 1,761,332 | 0 | 0 | ||
AVEO Pharmaceuticals, Inc. | COM | 053588109 | 2,615 | 1,429,174 | SH | SOLE | 1,429,174 | 0 | 0 | ||
Abiomed Inc. | COM | 003654100 | 71,860 | 2,687,347 | SH | SOLE | 2,687,347 | 0 | 0 | ||
Align Technology, Inc. | COM | 162551014 | 445 | 7,788 | SH | SOLE | 7,788 | 0 | 0 | ||
Alimera Sciences, Inc. | COM | 016259103 | 17,084 | 3,634,984 | SH | SOLE | 3,634,984 | 0 | 0 | ||
Amicus Therapeutics, Inc. | COM | 03152W109 | 9,420 | 4,008,576 | SH | SOLE | 4,008,576 | 0 | 0 | ||
Anacor Pharmaceuticals, Inc. | COM | 032420101 | 26,903 | 1,603,278 | SH | SOLE | 1,603,278 | 0 | 0 | ||
Ariad Pharmaceuticals, Inc. | COM | 04033A100 | 23,470 | 3,441,324 | SH | SOLE | 3,441,324 | 0 | 0 | ||
Auxilium Pharmaceuticals, Inc. | COM | 05334D107 | 101,243 | 4,883,879 | SH | SOLE | 4,883,879 | 0 | 0 | ||
Biomarin Pharmaceuticals, Inc | COM | 09061G101 | 52,135 | 741,087 | SH | SOLE | 741,087 | 0 | 0 | ||
Celgene Corp. | COM | 151020104 | 438 | 2,590 | SH | SOLE | 2,590 | 0 | 0 | ||
Clovis Oncology Inc. | COM | 189464100 | 11,264 | 186,900 | SH | SOLE | 186,900 | 0 | 0 | ||
Cubist Pharmaceuticals, Inc. | COM | 229678107 | 92,020 | 1,336,136 | SH | SOLE | 1,336,136 | 0 | 0 | ||
Cyberonics, Inc. | COM | 23251P102 | 127,676 | 1,951,581 | SH | SOLE | 1,951,581 | 0 | 0 | ||
Cytokinetics Inc. | COM | 23282W605 | 1,513 | 232,808 | SH | SOLE | 232,808 | 0 | 0 | ||
Exact Sciences Corp | COM | 30063P105 | 9,233 | 785,776 | SH | SOLE | 785,776 | 0 | 0 | ||
Hyperion Therapeutics | COM | 44915N101 | 1,268 | 62,700 | SH | SOLE | 62,700 | 0 | 0 | ||
Insmed, Inc. | COM | 457669307 | 4,967 | 292,199 | SH | SOLE | 292,199 | 0 | 0 | ||
Intermune Inc. | COM | 45884X103 | 56,263 | 3,819,606 | SH | SOLE | 3,819,606 | 0 | 0 | ||
Kythera BioPharm CMN | COM | 501570105 | 33,636 | 900,559 | SH | SOLE | 900,559 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | COM | 60877T100 | 20,461 | 1,157,276 | SH | SOLE | 1,157,276 | 0 | 0 | ||
NPS Pharmaceuticals | COM | 62936P103 | 13,331 | 439,100 | SH | SOLE | 439,100 | 0 | 0 | ||
Prothena Corp PLC | COM | G72800108 | 14,252 | 537,418 | SH | SOLE | 537,418 | 0 | 0 | ||
QLT Inc. | COM | 746927102 | 11,437 | 2,053,311 | SH | SOLE | 2,053,311 | 0 | 0 | ||
Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | 52,490 | 963,995 | SH | SOLE | 963,995 | 0 | 0 | ||
Rigel Pharmaceuticals Inc. | COM | 766559603 | 14,868 | 5,217,001 | SH | SOLE | 5,217,001 | 0 | 0 | ||
STAAR Surgical Company | COM | 852312305 | 52,039 | 3,214,253 | SH | SOLE | 3,214,253 | 0 | 0 | ||
Sequenom Inc. | COM | 817337405 | 21,983 | 9,394,627 | SH | SOLE | 9,394,627 | 0 | 0 | ||
Sophiris Bio Inc | COM | 83578Q209 | 1,084 | 292,900 | SH | SOLE | 292,900 | 0 | 0 | ||
Spectrum Pharmaceuticals Inc. | COM | 84763A108 | 3,560 | 402,285 | SH | SOLE | 402,285 | 0 | 0 | ||
United Therapeutics Corp | COM | 91307C102 | 123,871 | 1,095,428 | SH | SOLE | 1,095,428 | 0 | 0 | ||
Vanda Pharmaceutical Inc. | COM | 921659108 | 40,191 | 3,238,624 | SH | SOLE | 3,238,624 | 0 | 0 | ||
ViroPharma Incorporated | COM | 928241108 | 14,502 | 290,916 | SH | SOLE | 290,916 | 0 | 0 | ||
Xoma Ltd. | COM | 98419J107 | 1,724 | 256,100 | SH | SOLE | 256,100 | 0 | 0 |